Samsung Biologics Co.,Ltd. (KRX:207940)

Samsung Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 25, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	75,871,484	67,544,126	54,092,240	58,433,854	59,746,995	54,652,290
Market Cap Growth	22.02%	24.87%	-7.43%	-2.20%	9.32%	90.76%
Enterprise Value	76,005,751	67,525,830	54,470,492	57,778,382	59,669,232	54,358,190
Last Close Price	1066000.00	949000.00	760000.00	821000.00	893509.47	817318.74
PE Ratio	59.30	62.35	63.07	73.22	151.80	226.80
Forward PE	48.74	62.18	60.08	82.37	112.20	-
PS Ratio	15.49	14.85	14.64	19.47	38.10	46.92
PB Ratio	6.73	6.19	5.50	6.50	11.97	11.88
P/TBV Ratio	8.87	8.52	8.23	10.14	12.05	11.95
P/FCF Ratio	373.53	189.90	80.60	-	1235.91	875.48
P/OCF Ratio	36.97	40.71	32.46	61.31	131.43	270.44
PEG Ratio	2.27	3.19	3.45	8.15	3.45	-
EV/Sales Ratio	15.52	14.85	14.74	19.25	38.05	46.67
EV/EBITDA Ratio	34.19	35.19	33.97	44.72	85.35	124.54
EV/EBIT Ratio	47.38	51.15	48.91	58.74	111.05	185.66
EV/FCF Ratio	374.19	189.85	81.16	-	1234.30	870.77
Debt / Equity Ratio	0.13	0.14	0.19	0.28	0.26	0.17
Debt / EBITDA Ratio	0.64	0.77	1.19	1.95	1.85	1.80
Debt / FCF Ratio	6.99	4.18	2.85	-	26.74	12.57
Asset Turnover	0.29	0.27	0.23	0.24	0.22	0.19
Inventory Turnover	0.84	0.83	0.76	0.91	1.02	1.37
Quick Ratio	0.36	0.35	0.50	0.76	1.24	1.45
Current Ratio	1.45	1.43	1.33	1.54	2.55	2.97
Return on Equity (ROE)	12.02%	10.45%	9.12%	11.42%	8.21%	5.38%
Return on Assets (ROA)	5.84%	4.94%	4.27%	5.01%	4.67%	2.97%
Return on Capital (ROIC)	8.12%	6.84%	5.99%	6.91%	5.76%	3.52%
Return on Capital Employed (ROCE)	11.50%	9.80%	9.40%	7.90%	7.80%	5.00%
Earnings Yield	1.69%	1.60%	1.59%	1.37%	0.66%	0.44%
FCF Yield	0.27%	0.53%	1.24%	-0.01%	0.08%	0.11%
Buyback Yield / Dilution	-	-	-1.95%	-5.51%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.